Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07751965 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR

Study acronym: MARVELTAVI
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Ceric Sàrl
10 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Prospective study is designed to evaluate the safety and efficacy of Myval THV series in patients with severe symptomatic non- or mild-calcified aortic regurgitation.
Trial Details
NCT Number NCT07751965
Lead Sponsor Ceric Sàrl
Conditions
(from sponsor)		 Aortic Regurgitation, Aortic Disease, Calcified Aortic Valve
Related terms Aortic Diseases, Aortic Valve Insufficiency, Aortic Valve, Calcification of
Enrollment 164 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov